Cargando…

Morbidity and mortality in patients with hyperprolactinaemia: the PROLEARS study

PURPOSE: High serum prolactin concentrations have been associated with adverse health outcomes in some but not all studies. This study aimed to examine the morbidity and all-cause mortality associated with hyperprolactinaemia. METHODS: A population-based matched cohort study in Tayside (Scotland, UK...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soto-Pedre, Enrique, Newey, Paul J, Bevan, John S, Leese, Graham P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633062/ https://www.ncbi.nlm.nih.gov/pubmed/28954743 http://dx.doi.org/10.1530/EC-17-0171

Ejemplares similares

Morbidity Associated With Primary Hyperparathyroidism—A Population-based Study With a Subanalysis on Vitamin D
por: Soto-Pedre, Enrique, et al.
Publicado: (2023)

Stable Incidence and Increasing Prevalence of Primary Hyperparathyroidism in a Population-based Study in Scotland
por: Soto-Pedre, Enrique, et al.
Publicado: (2023)

Hyperprolactinaemia
por: Samperi, Irene, et al.
Publicado: (2019)

Hyperprolactinaemia with amisulpride
por: Raj, Rajnish, et al.
Publicado: (2008)

Identification of 4 New Loci Associated With Primary Hyperparathyroidism (PHPT) and a Polygenic Risk Score for PHPT
por: Soto-Pedre, Enrique, et al.
Publicado: (2022)

Hyperprolactinaemia--investigation and results of treatment.
por: Wilson, J. D., et al.
Publicado: (1980)

Hyperprolactinaemia: audit of practice and new guidance
por: Janaway, Benjamin, et al.
Publicado: (2021)

Altered immunoglobulin G glycosylation in patients with isolated hyperprolactinaemia
por: Hirschberg, Daniel, et al.
Publicado: (2021)

Hyperprolactinaemia in male infertility: Clinical case scenarios
por: Dabbous, Zeinab, et al.
Publicado: (2017)

Hyperprolactinaemia – a problem in patients from the reproductive period to the menopause
por: Pałubska, Sylwia, et al.
Publicado: (2017)

Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas
por: Schwetz, Verena, et al.
Publicado: (2016)

Galactorrhoea and Hyperprolactinaemia in a Non-Pregnant Female with Burns
por: van Heerden, Marli, et al.
Publicado: (2020)

Hyperprolactinaemia is common in Chinese premenopausal women with breast diseases
por: Zhu, Jiang, et al.
Publicado: (2023)

Clinical Presentations of Drug-Induced Hyperprolactinaemia: A Literature Review
por: Junqueira, Daniela R., et al.
Publicado: (2023)

Aetiologies of Hyperprolactinaemia: A retrospective analysis from a tertiary healthcare centre
por: Malik, Azhar A., et al.
Publicado: (2019)

Adjunctive aripiprazole for antipsychotic-related hyperprolactinaemia in patients with first-episode schizophrenia: a meta-analysis
por: Zheng, Wei, et al.
Publicado: (2019)

Polymorphism in INSR Locus Modifies Risk of Atrial Fibrillation in Patients on Thyroid Hormone Replacement Therapy
por: Soto-Pedre, Enrique, et al.
Publicado: (2021)

Galactocele in a Male Infant with Transient Hyperprolactinaemia: An Extremely Rare Cause of Breast Enlargement in Children
por: Lau, C. T., et al.
Publicado: (2016)

Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial
por: Raghuthaman, G., et al.
Publicado: (2015)

Ectopic hyperprolactinaemia due to a malignant uterine tumor resembling ovarian sex cord tumors (UTROCST)
por: Dimitriadis, Georgios K., et al.
Publicado: (2020)

Prolactin-Secreting Leiomyoma Causing Hyperprolactinaemia Unresponsive to Dopamine Agonist Therapy and Resolution following Myomectomy
por: Barry, Lucinda, et al.
Publicado: (2021)

Adjunctive Peony-Glycyrrhiza decoction for antipsychotic-induced hyperprolactinaemia: a meta-analysis of randomised controlled trials
por: Zheng, Wei, et al.
Publicado: (2018)

Data of a meta-analysis on pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia
por: Labad, Javier, et al.
Publicado: (2020)

Association between 8 P‐glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug‐induced hyperprolactinaemia
por: Geers, Lisanne M., et al.
Publicado: (2020)

The effect of short-term metformin treatment on plasma prolactin levels in bromocriptine-treated patients with hyperprolactinaemia and impaired glucose tolerance: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2014)

Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: a joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology
por: Steeds, Richard P, et al.
Publicado: (2019)

Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: A GoDarts study
por: Connelly, Paul J., et al.
Publicado: (2017)

The risk of total mortality and cardiovascular mortality associated with impaired glucose regulation in Tayside, Scotland, UK: a record-linkage study in 214 094 people
por: Evans, Josie M M, et al.
Publicado: (2015)

Mortality, morbidity and economic growth
por: Rocco, Lorenzo, et al.
Publicado: (2021)

The Morbidity and Mortality of Laparoscopic Appendectomy in Patients with Cirrhosis
por: Al-Azzawi, Yasir, et al.
Publicado: (2018)

Cardiovascular Morbidity and Mortality in Adult Patients With Repaired Aortic Coarctation
por: Meijs, Timion A., et al.
Publicado: (2021)

Effect of Diabetes on Morbidity and Mortality in Patients With Acromegaly
por: Esposito, Daniela, et al.
Publicado: (2022)

MATERNAL MORTALITY AND MORBIDITY
Publicado: (1934)

Maternal Mortality and Morbidity
Publicado: (1934)

Maternal Morbidity and Mortality
por: Noursi, Samia, et al.
Publicado: (2021)

Mortality and morbidity in patients with atrial fibrillation and liver cirrhosis
por: Darrat, Yousef H, et al.
Publicado: (2020)

Morbidity and mortality study of shale oil workers in the United States.
por: Costello, J
Publicado: (1979)

Characteristics of people with high visit‐to‐visit glycaemic variability in Type 2 diabetes
por: Noyes, J. D., et al.
Publicado: (2017)

The Significant Morbidity and Mortality Indicators in Patients of Cirrhosis
por: Mallik, Manaswinee, et al.
Publicado: (2022)

Trends in Pulmonary Hypertension Mortality and Morbidity
por: Mehari, Alem, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_00dbjoc9g8kmgacntm33nbdp54